301 related articles for article (PubMed ID: 11085892)
21. [Gene therapy for ischemic stroke].
Abe K
Brain Nerve; 2008 Nov; 60(11):1373-81. PubMed ID: 19069172
[TBL] [Abstract][Full Text] [Related]
22. Herpes simplex virus vector-mediated delivery of glial cell line-derived neurotrophic factor rescues erectile dysfunction following cavernous nerve injury.
Kato R; Wolfe D; Coyle CH; Huang S; Wechuck JB; Goins WF; Krisky DM; Tsukamoto T; Nelson JB; Glorioso JC; Chancellor MB; Yoshimura N
Gene Ther; 2007 Sep; 14(18):1344-52. PubMed ID: 17611585
[TBL] [Abstract][Full Text] [Related]
23. Neuropathological and behavioral consequences of adeno-associated viral vector-mediated continuous intrastriatal neurotrophin delivery in a focal ischemia model in rats.
Andsberg G; Kokaia Z; Klein RL; Muzyczka N; Lindvall O; Mandel RJ
Neurobiol Dis; 2002 Mar; 9(2):187-204. PubMed ID: 11895371
[TBL] [Abstract][Full Text] [Related]
24. Delayed delivery of AAV-GDNF prevents nigral neurodegeneration and promotes functional recovery in a rat model of Parkinson's disease.
Wang L; Muramatsu S; Lu Y; Ikeguchi K; Fujimoto K; Okada T; Mizukami H; Hanazono Y; Kume A; Urano F; Ichinose H; Nagatsu T; Nakano I; Ozawa K
Gene Ther; 2002 Mar; 9(6):381-9. PubMed ID: 11960314
[TBL] [Abstract][Full Text] [Related]
25. Lentiviral vectors as a gene delivery system in the mouse midbrain: cellular and behavioral improvements in a 6-OHDA model of Parkinson's disease using GDNF.
Bensadoun JC; Déglon N; Tseng JL; Ridet JL; Zurn AD; Aebischer P
Exp Neurol; 2000 Jul; 164(1):15-24. PubMed ID: 10877911
[TBL] [Abstract][Full Text] [Related]
26. Delivery of GDNF by an E1,E3/E4 deleted adenoviral vector and driven by a GFAP promoter prevents dopaminergic neuron degeneration in a rat model of Parkinson's disease.
Do Thi NA; Saillour P; Ferrero L; Dedieu JF; Mallet J; Paunio T
Gene Ther; 2004 May; 11(9):746-56. PubMed ID: 14724667
[TBL] [Abstract][Full Text] [Related]
27. Bcl-2 and GDNF delivered by HSV-mediated gene transfer act additively to protect dopaminergic neurons from 6-OHDA-induced degeneration.
Natsume A; Mata M; Goss J; Huang S; Wolfe D; Oligino T; Glorioso J; Fink DJ
Exp Neurol; 2001 Jun; 169(2):231-8. PubMed ID: 11358438
[TBL] [Abstract][Full Text] [Related]
28. Adeno-associated virus-mediated delivery of BCL-w gene improves outcome after transient focal cerebral ischemia.
Sun Y; Jin K; Clark KR; Peel A; Mao XO; Chang Q; Simon RP; Greenberg DA
Gene Ther; 2003 Jan; 10(2):115-22. PubMed ID: 12571640
[TBL] [Abstract][Full Text] [Related]
29. Suppression of choroidal neovascularization by adeno-associated virus vector expressing angiostatin.
Lai CC; Wu WC; Chen SL; Xiao X; Tsai TC; Huan SJ; Chen TL; Tsai RJ; Tsao YP
Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2401-7. PubMed ID: 11527956
[TBL] [Abstract][Full Text] [Related]
30. Gene treatment of cerebral stroke by rAAV vector delivering IL-1ra in a rat model.
Tsai TH; Chen SL; Xiao X; Chiang YH; Lin SZ; Kuo SW; Liu DW; Tsao YP
Neuroreport; 2003 May; 14(6):803-7. PubMed ID: 12858036
[TBL] [Abstract][Full Text] [Related]
31. T155g-immortalized kidney cells produce growth factors and reduce sequelae of cerebral ischemia.
Dillon-Carter O; Johnston RE; Borlongan CV; Truckenmiller ME; Coggiano M; Freed WJ
Cell Transplant; 2002; 11(3):251-9. PubMed ID: 12075990
[TBL] [Abstract][Full Text] [Related]
32. Targeted retrograde gene delivery of brain-derived neurotrophic factor suppresses apoptosis of neurons and oligodendroglia after spinal cord injury in rats.
Nakajima H; Uchida K; Yayama T; Kobayashi S; Guerrero AR; Furukawa S; Baba H
Spine (Phila Pa 1976); 2010 Mar; 35(5):497-504. PubMed ID: 20190624
[TBL] [Abstract][Full Text] [Related]
33. Pitx3-transfected astrocytes secrete brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor and protect dopamine neurons in mesencephalon cultures.
Yang D; Peng C; Li X; Fan X; Li L; Ming M; Chen S; Le W
J Neurosci Res; 2008 Nov; 86(15):3393-400. PubMed ID: 18646205
[TBL] [Abstract][Full Text] [Related]
34. [Gene-stem Cell therapy for ischemic stroke].
Abe K
Brain Nerve; 2009 Sep; 61(9):1043-9. PubMed ID: 19803403
[TBL] [Abstract][Full Text] [Related]
35. Brain area, age and viral vector-specific glial cell-line-derived neurotrophic factor expression and transport in rat.
Kanter-Schlifke I; Georgievska B; Kirik D; Kokaia M
Neuroreport; 2007 Jun; 18(9):845-50. PubMed ID: 17515788
[TBL] [Abstract][Full Text] [Related]
36. Adenoviral GDNF gene transfer enhances neurofunctional recovery after recurrent laryngeal nerve injury.
Araki K; Shiotani A; Watabe K; Saito K; Moro K; Ogawa K
Gene Ther; 2006 Feb; 13(4):296-303. PubMed ID: 16251996
[TBL] [Abstract][Full Text] [Related]
37. [Regulation of AAV-mediated glial cell-line derived neurotrophic factor expression by using improved Tet-on trans-activator].
Chen T; Li XG; Wu CY; Takashi O; Keiya O
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(6):405-8. PubMed ID: 15854532
[TBL] [Abstract][Full Text] [Related]
38. Neuroprotection of adenoviral-vector-mediated GDNF expression against kainic-acid-induced excitotoxicity in the rat hippocampus.
Yoo YM; Lee CJ; Lee U; Kim YJ
Exp Neurol; 2006 Aug; 200(2):407-17. PubMed ID: 16690057
[TBL] [Abstract][Full Text] [Related]
39. Astrocyte delivery of glial cell line-derived neurotrophic factor in a mouse model of Parkinson's disease.
Cunningham LA; Su C
Exp Neurol; 2002 Apr; 174(2):230-42. PubMed ID: 11922664
[TBL] [Abstract][Full Text] [Related]
40. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.
Zheng JS; Tang LL; Zheng SS; Zhan RY; Zhou YQ; Goudreau J; Kaufman D; Chen AF
Brain Res Mol Brain Res; 2005 Mar; 134(1):155-61. PubMed ID: 15790539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
